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Abstract
Purpose The purpose of this systematic review was to com-
pare minimally invasive pancreatoduodenectomy (MIPD)
versus open pancreatoduodenectomy (OPD) by using meta-
analytical techniques.
Methodology Medline, Embase, and Cochrane Library were
searched for eligible studies. Data from included studies were
extracted for the following outcomes: operative time, overall
morbidity, pancreatic fistula, delayed gastric emptying, blood
loss, postoperative hemorrhage, yield of harvested lymph
nodes, R1 rate, length of hospital stay, and readmissions.
Random and fix effect meta-analyses were undertaken.
Results Initial reference search yielded 747 articles. Thorough
evaluation resulted in 12 papers, which were analyzed. The
total number of patients was 2186 (705 in MIPD group and
1481 in OPD). Although there were no differences in overall
morbidity between groups, we noticed reduced blood loss,
delayed gastric emptying, and length of hospital stay in favor
ofMIPD. In contrary, meta-analysis of operative time revealed
significant differences in favor of open procedures.
Remaining parameters did not differ among groups.
Conclusion Our review suggests that although MIPD takes
longer, it may be associated with reduced blood loss, short-
ened LOS, and comparable rate of perioperative complica-
tions. Due to heterogeneity of included studies and differences
in baseline characteristics between analyzed groups, the anal-
ysis of short-term oncological outcomes does not allow draw-
ing unequivocal conclusions.
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Introduction
It has been documented that minimally invasive surgerymay be
successfully and safely applied to practically every
intraabdominal surgical operation. Although the first total lap-
aroscopic pancreatoduodenectomy was described more than
20 years ago by Gagner and Pomp, it still has not become the
gold standard in the treatment of periampullary malignancies
[1]. Globally, there is a trend in oncological surgery towards the
reduction of surgical trauma (introduction of minimally inva-
sive surgery, changes in the operative technique, organ sparing
procedures, modification of perioperative care) [2, 3]. Although
there is a lack of randomized trials in the field of minimally
invasive pancreatic head resections, a growing number of case
series and cohort studies have been published comparing the
safety and efficacy of minimally invasive and open pancreatic
head resection [4]. In many centers performing laparoscopic or
robotic pancreatic head resections, these procedures are in fact
not minimally invasive pancreatoduodenectomies (MIPD) but
rather cases in which the dissection is being performed in a
minimally invasive manner, while anastomoses are performed
manually [5–9]. This could potentially create a bias in the anal-
ysis of outcomes.
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Since it has been shown that laparoscopic approach is fea-
sible in other types of procedures in oncological surgery (e.g.,
gastric, colorectal), we hypothesized it might also be achiev-
able in pancreatic head resections [10, 11]. Therefore, in this
review, we aimed to systematically review the available pub-
lished literature and conduct a meta-analysis comparing min-
imally invasive (laparoscopic or robotic) and open
pancreatoduodenectomy.
Methods
Study selection
A systematic review of the literature was performed using the
Medline, Embase, and Cochrane databases to identify all eligible
studies that comparedMIPDversus open pancreatoduodenectomy
(OPD). The used search terms included Blaparoscopy,^
Bminimally invasive,̂ Blaparoscopic assisted,̂ Brobotic,̂ robot-
i c - a s s i s t e d , ^ Bp a n c r e a t o d u o d e n e c t o m y , ^
Bpancreaticoduodenectomy,^ BWhipple,^ BTraverso,^
Bpancreatic head resection,^ and Bduodenopancreatectomy .̂
These terms were combined using Boolean operators BAND^
and BOR^. References of the acquired articles were also hand-
searched. Most recent search was done on 5th February, 2017.
Ovid search strategy is available in supplementary file 1.
Data extraction
All references were reviewed and evaluated by two re-
searchers. In case of doubt about inclusion, a third reviewer
was consulted until consensus was reached. Only full length
articles were eligible for extraction. When included, the fol-
lowing data were extracted: first author, year of publication,
study design, number of operated subjects, 30-day readmis-
sion, conversion rate, perioperative, and short-term oncologi-
cal outcomes.
Inclusion criteria
Studies eligible for further analysis had to fulfill the following
criteria: (1) comparison of characteristics and perioperative
outcomes ofmini-invasive techniques (laparoscopic or robotic
surgery) to open approach in patients undergoing
pancreatoduodenectomy, (2) objective evaluation of operative
time and reports of pancreatic fistula, and (3) no language
restrictions were used.
Exclusion criteria
Studies were excluded when (1) lack of comparative data, (2)
hand-assisted technique in the description of surgical method-
ology (especially anastomoses) or surgical method was
unclear, (3) lack of primary outcomes or insufficient data to
analyze, (4) studies regarding techniques other than
pancreatoduodenectomy, and (5) extraction of data only on
pancreatoduodenectomy not possible.
Outcomes of interest
MIPD (excluding hand-assisted) and OPD were compared on
the basis of perioperative outcomes (operative time, intraop-
erative blood loss), postoperative complications (overall mor-
bidity, pancreatic fistula, delayed gastric emptying, postoper-
ative hemorrhage), oncologic safety (lymph node harvest, R1
rate), length of hospital stay, and 30-day readmission rate.
Statistical analysis
Analysis was performed using RevMan 5.3 (freeware from
The Cochrane Collaboration). Statistical heterogeneity and
inconsistency were measured using Cochran’s Q tests and
I2, respectively. Qualitative outcomes from individual studies
were analyzed to assess individual and pooled risk ratios (RR)
with pertinent 95% confidence intervals (CI) favoring mini-
mally invasive over open pancreatoduodenectomy and by
means of the Mantel-Haenszel fixed-effects method in the
presence of low or moderate statistical inconsistency
(I2 ≤ 10%) and by means of a random-effects method (which
better accommodates clinical and statistical variations) in the
presence of high statistical inconsistency (I2 > 10%). When
appropriate, mean and standard deviation were calculated
from medians and interquartile ranges using a method pro-
posed by Hozo et al. [12]. Weighted mean differences
(WMD) with 95% CI are presented for quantitative variables
using the inverse variance fixed-effects or random-effects
method. Statistical significance was observed with two-tailed
0.05 level for hypothesis and with 0.10 for heterogeneity test-
ing, while unadjusted p values were reported accordingly.
Non-randomized studies were evaluated by the Newcastle–
Ottawa Scale (NOS), which consists of three factors: patient
selections, comparability of the study groups, and assessment
of outcomes. A score of 0 to 9 was assigned to each study, and
studies achieving a score of 6 or greater were considered high
quality. This study was performed according to the Preferred
Reporting Items for Systematic reviews (PRISMA) guidelines
and MOOSE consensus statement [13, 14].
Results
Initial reference search yielded 747 articles. After removing
185 duplicates, 562 articles had their titles and abstracts eval-
uated. This resulted in 83 papers suitable for full-text review,
where 19 studies were review articles on the subject of
pancreatoduodenectomy, 20 articles were excluded due to
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wrong study design, 23 because of the wrong type of inter-
vention, three studies were based on national registries, and
two did not provide sufficient data for inclusion. Four studies
by Asbun et al., Stauffer et al. Mesleh et al., and Gumbs et al.
met inclusion criteria; however, it was impossible to extract
data on pancreatoduodenectomy alone. Besides, three of them
included patients from the same pancreatic center treated in
the overlapping period of time [15–18]. Thus, they were ex-
cluded from further analysis. Finally, we enrolled 12 studies
with a total of 2186 patients (705 underwent MIPD and 1481
underwent open procedure) (Table 1) [19–30]. Quality of the
analyzed studies according to NOS is high, with majority of
studies scoring ≥7 out of 9. Authors were contacted to provide
additional data on their studies. Flowchart of the analyzed
studies is presented in Fig. 1.
The analysis revealed that MIPD group differed signifi-
cantly in tumor size (reported in eight studies) in comparison
to open approach (2.63 vs 3.26 cm, MD = −0.46 CI 95%
−0.72–−0.20, p = 0.0005).
The operative time was reported by all authors. The mean
total operative time for MIPD was 464 min, whereas for open
procedure, it was 388 min. A subgroup analysis showed a mean
value of 427 min for laparoscopic pancreatoduodenectomy and
482min for robotic procedures. The analysis (Fig. 2) showed that
the operative timewas significantly shorter in the open procedure
group: MD = 64.09, 95% CI 23.97–104.21, p for effect = 0.002,
p for heterogeneity <0.00001, I2 = 94%. However, a subgroup
analysis revealed no statistically significant differences in both
laparoscopic and robotic subgroup, which, together with high
heterogeneity, limits the quality of evidence of this outcome.
Conversions were reported by eight authors. There were 31
(6.01%) conversions in total, with 11 (7.23%) in laparoscopic
group and 20 (5.49%) in robotic.
Data on blood loss was presented in 10 of 12 studies. All
authors, except Baker et al., Lai et al., and Zureikat et al.,
reported significant differences in this outcome. Mean blood
loss for laparoscopic group was 350.8, 339.04 ml for robotic
group, and 342.57 ml for the whole MIPD group, whereas in
Table 1 Study characteristics
Author Year Country Study
design
Type of
intervention
Number of patients
MIPD/OPD
Conversion
rate
Neoadjuvant
chemotherapy
MIPD/OPD
Vein resection
MIPD/OPD
Quality score
(9 max.)
Baker et al.
[19]
2016 USA RS, SC RPD 22/49 14% 11.1/12.5% 13.6/14.3% 7
Bao et al.
[20]
2014 USA RS,
CM,
SC
RPD 28/28 14% ND ND 6
Boggi et al.
[21]
2016 Italy RS, SC RPD 83/36 2% ND 8.4/11.1% 8
Buchs et al.
[22]
2011 USA RS, SC RPD 44/39 ND ND ND 8
Chen et al.
[23]
2015 China PS,
CM,
SC
RPD 60/120 ND ND 5.0/6.7% 8
Lai and
Tang
[24]
2012 China RS, SC RPD 20/67 5% ND ND 6
Zhou et al.
[25]
2011 China RS, SC RPD 8/6 ND ND ND 8
Zureikat
et al.
[26]
2016 USA RS,MC RPD 211/817 4.7% ND ND 7
Croome
et al.
[27]
2014 USA RS, SC LPD 108/214 6% 11.1/14.0% 20.4/23.8% 8
Delitto
et al.
[28]
2016 USA PS, SC LPD 77/61 ND 5.8/6.0% ND 7
Tan et al.
[29]
2015 China RS,MC LPD 30/30 7% ND ND 6
Zureikat
et al.
[30]
2011 USA RS,
CM,
SC
LPD 14/14 14% ND 7.1/0.0% 7
LPD laparoscopic pancreatoduodenectomy, RPD robotic pancreatoduodenectomy, OPD open pancreatoduodenectomy, RS retrospective study, PS
prospective study, SC single center, MC multi center, CM case matched, ND no data, MIPD minimally invasive pancreatoduodenectomy
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the case of open procedure, it was 534.67 ml. The analysis
(Fig. 3) revealed a significant difference in both subgroups, as
well as in total: MD = −190.65, 95% CI −265.40–−115.89, p
for effect <0.00001, p for heterogeneity <0.00001, I2 = 81%.
Overall morbidity was reported in 10 of 12 studies. Authors
Bao and Croome were contacted to provide necessary data,
with no response. Of all studies, only two authors, Delitto and
Zhou, reported a significant difference in morbidity in ana-
lyzed groups. Meta-analysis of all included studies, as well
as subgroup analysis, did not show statistically significant
differences: 241/569 (42.36%) in MIPD and 446/1239
(36.00%) in the control group, RR = 0.84, 95% CI 0.68–
1.04, p for effect = 0.12, p for heterogeneity = 0.0004,
I2 = 70% (Fig. 4).
All authors reported events of pancreatic fistula formation.
International Study Group on Pancreatic Fistula (ISGPF)
definition was used in 10 studies, while the remaining two
described the definition of fistula in study methodology.
Only one study, by Delitto et al., showed a significant differ-
ence in occurrence of fistula rate in favor of MIPD, whereas
Zureikat et al. in their study from 2016 present data in favor of
open approach. There were no significant variations among
the studied groups: 132/705 (18.72%) inMIPD group vs. 204/
1481 (13.77%) in control group, RR = 1.04, 95% CI 0.77–
1.41, p for effect = 0.78, p for heterogeneity = 0.04, I2 = 42%
(Fig. 5).
Delayed gastric emptying was reported in eight studies.
Only one, by Croome et al., showed a significant difference
in rate of delayed gastric emptying in favor of MIPD.
Subgroup analysis (Fig. 6) revealed a significant decrease in
occurrence of delayed gastric emptying in the laparoscopic
group (p = 0.04, 95% CI 0.29–0.97), whereas this was not
present in the robotic subgroup (p = 0.19, 95% CI 0.62–1.1).
In total, there was a significant variation in the rate of delayed
gastric emptying with 73/395 (18.48%) in MIPD group and
110/583 (18.87%) in the open approach group: RR = 0.77,
95% CI 0.59–0.99, p for effect = 0.04, p for heterogene-
ity = 0.59, I2 = 0%.
Postoperative hemorrhage was reported in six studies.
None of the studies favored particular approach. There were
no statistical significant differences in among analyzed
groups: RR = 1.11, 95% CI 0.63–1.93, p for effect = 0.72, p
for heterogeneity = 0.91, I2 = 0%.
The number of harvested lymph nodes was reported in nine
studies. There were no significant variations among the ana-
lyzed groups, both in total and in subgroup analysis:
MD = 1.61, 95% CI −1.15–4.38, p for effect = 0.25, p for
heterogeneity <0.0001, I2 = 94% (Fig. 7). Due to high hetero-
geneity, a sensitivity analysis was performed. Three studies by
Buchs et al., Bao et al., and Zureikat et al. (2016) were iden-
tified as the cause for most heterogeneity. Analysis without
these studies provided heterogeneity with I2 = 45%; however,
the result was still stastically insignificant, p = 0.44.
R1 resection rate calculated separately for pancreatic ma-
lignancy was reported in 11/12; however, only in six extrac-
tion for pancreatic adenocarcinoma was possible. Of all stud-
ies, Zureikat et al. (2016) reported data in favor of open ap-
proach. Analysis of these six studies revealed no significant
difference between the groups, 62/223 (27.80%) in MIPD vs.
200/727 (27.51%) in open approach group, p for effect= 0.77,
RR = 0.92, 95% CI 0.51–1.64, p for heterogeneity = 0.03,
I2 = 59% (Fig. 8).
Mean length of hospital (LOS) stay was reported in all
papers, and in all of them, it included primary LOS (excluding
potential readmissions). There was a significant reduction in
LOS in the subgroup of laparoscopic surgery. Mean LOS for
laparoscopic surgery was 8.2 days, while for the control
group, it was 9.79 days (MD = −2.24, 95%CI −2.24–−0.80,
p = 0.002). There were no statistical variations in LOS in the
Fig. 1 Flowchart of the studies
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robotic group; however, authors Zhou, Lai, and Chen reported
in their papers a significant reduction of LOS in the MIPD,
whereas Boggi presented data favoring open approach. The
analysis (Fig. 9) showed significant differences between stud-
ied groups in total: MD = −1.88, 95%CI −3.62–0.14, p for
effect = 0.03, p for heterogeneity <0.0001, I2 = 79%.
Thirty-day readmission rate was reported in three studies.
The analysis revealed no stastically significant differences
among analyzed groups, RR = 1.05, 95% CI 0.59–1.87, p
for effect = 0.88, p for heterogeneity = 0.59, I2 = 0%.
Discussion
This systematic review, based on 12 comparative studies of
minimally invasive pancreatoduodenectomy (four laparo-
scopic and eight robotic) enrolling 2186 patients, 705 in the
MIPD group and 1481 in the open group, documents the fea-
sibility and potential benefits of minimally invasive
pancreatoduodenectomy. The subsequent meta-analysis of re-
sults showed that although MIPD takes longer, it is associated
with a reduced intraoperative blood loss, lower incidence of
Fig. 2 Pooled estimates of operative time comparing mini-invasive pancreatoduodenectomy versus open surgery. CI confidence interval, df degrees of
freedom
Fig. 3 Pooled estimates of blood loss comparing mini-invasive pancreatoduodenectomy versus open surgery. CI confidence interval, df degrees of
freedom
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Fig. 5 Pooled estimates of fistula cases comparing mini-invasive pancreatoduodenectomy versus open surgery. CI confidence interval, df degrees of
freedom
Fig. 4 Pooled estimates of morbidity comparing mini-invasive pancreatoduodenectomy versus open surgery. CI confidence interval, df degrees of
freedom
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delayed gastric emptying, and shorter LOS. Moreover, type of
surgery had no influence on overall morbidity, pancreatic fis-
tula rate, and number of harvested lymph nodes.
Laparoscopic PD was first described by Gagner and Pomp
in 1994, whereas first reports on robotic approach appeared
6 years later [1, 31]. Despite high popularity of minimally
invasive surgery in other surgical disciplines and all its unde-
niable benefits, MIPD has still not become the gold standard
in the treatment of periampullary tumors [32, 33]. While
performing this systematic review, we did not find any ran-
domized controlled trials on this topic; thus, the quality of
included studies is limited. To our knowledge, there are sev-
eral previously published systematic reviews comparing
MIPD with open approach [34–36]. However, in most of
them, there is a methodological bias due to the fact that they
include in their analysis studies which apart from
Fig. 6 Pooled estimates of delayed gastric emptying cases comparing mini-invasive pancreatoduodenectomy versus open surgery. CI confidence
interval, df degrees of freedom
Fig. 7 Pooled estimates of harvested lymph nodes comparing mini-invasive pancreatoduodenectomy versus open surgery. CI confidence interval, df
degrees of freedom
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pancreatoduodenectomy report pancreatectomies altogether.
They do not report parameters such as operative time, blood
loss, pancreatic fistula, overall morbidity, and LOS separately
for pancreatoduodenectomy and pancreatectomy, which
makes previous meta-analyses including these studies prone
to be biased. Therefore, in our review, we included only stud-
ies reporting clear data onMIPD, thus, limiting bias associated
with uncertain data.
MIPD is considered one of the most difficult and time-
consuming abdominal procedures, since it involves precise
perivascular dissection and demanding biliary and pancreatic
anastomoses. For these reasons, in some centers, the dissec-
tion is the only part performed via laparoscopy, whereas anas-
tomoses are constructed via minilaparotomy, which is obvi-
ously less complicated and time-consuming than with laparo-
scopic instruments. Therefore, to fully compare MIPD and
Fig. 9 Pooled estimates of length of hospital stay comparing mini-invasive pancreatoduodenectomy versus open surgery. CI confidence interval, df
degrees of freedom
Fig. 8 Pooled estimates of R1 resection comparing mini-invasive pancreatoduodenectomy versus open surgery. CI confidence interval, df degrees of
freedom
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open approach, we have decided to exclude all studies which
described hand-assisted methods. Studies inwhich themethod
description was unclear or it was stated that anastomoses were
performed extra- or intracorporeal (up to surgeon’s decision)
were excluded.
Mean tumor size in the MIPD group was significantly low-
er than in open group. This is probably due to case selection
for MIPD and, as long as there are no RCTs on this topic,
tumor size may create potential methodological bias. Other
tumor characteristics, such as malignant/benign character or
stage of cancer did not vary.
We have observed that operative time was longer in MIPD
group (464 vs. 388 min), which confirms the difficulty of the
procedure. Previous studies have estimated that at least 50
cases for laparoscopic and 33 (up to 80 in one report) for
robotic access are needed to achieve proficiency in performing
them [24, 37–39]. However, in all of them, operative time was
taken into consideration to establish the completion of the
learning curve. After all, achieving proficiency in such a dif-
ficult procedure cannot be limited only to reduction of opera-
tive time. It should also include other parameters such as pan-
creatic fistula rate, intraoperative blood loss, or other postop-
erative complications. Unfortunately, in most of selected stud-
ies, the experience of the surgical teamwas unclear, and it was
not stated whether the surgical team has completed the learn-
ing curve, and for this reason, analysis of outcomes may be
biased. In addition, there is a tendency that even beyond the
completion of defined learning curves, a selection bias may be
present. Therefore, well-matched trials or randomization is
needed to eliminate this element. On the other hand, reduced
blood loss seems typical for minimally invasive procedures,
since it is desired for appropriate visualization of the operating
field. It is not surprising that most of the studies reporting
blood loss showed its reduction in MIPD groups.
Perhaps the most important aspect from a surgeon’s per-
spective is the comparison of complication rates, LOS, and
oncological outcomes. Our review did not find any differences
in overall morbidity between MIPD and OPD. Although we
have found that delayed gastric emptying rate was statistically
lower in MIPD group, the difference was clinically irrelevant
(18.48 vs. 18.87%). Pancreatic fistula rates remained similar,
irrespective of surgical approach. Even though available evi-
dence of included studies suggests that MIPD does not signif-
icantly improve outcomes in terms of morbidity, it may guar-
antee the possibility of noninferiority. This is also confirmed
by a similar number of harvested lymph nodes in both groups.
Additionally, we have observed that R1 rate was similar in
both groups. However, it has to be emphasized that there were
differences in baseline tumor sizes between groups, which
with no doubt biases this result. Indeed, it is well-established
that tumor size is an important feature of pancreatic head can-
cer and correlates strongly with incomplete resection rate [40,
41]. Besides, there was no information on the pathology
protocol, which could vary among studies, leading to biased
results [42–44]. Moreover, an overall reduction in LOS was
seen but with relatively high heterogeneity. This may be ex-
plained by other factors that are related to LOS (perioperative
care protocols and different discharge criteria).
Our review has some important limitations which are relat-
ed to available studies. It does not consist of any randomized
study, which limits the level of evidence. In addition, it con-
tains results of several specialized, high-volume centers and
probably cannot be easily transferred to departments with low-
er annual case volume. Moreover, high statistical heterogene-
ity was found among included studies. For some parameters, it
reached 90% which limits the quality of results and may even
question performing such meta-analysis. However, we have
decided to show that there is still little evidence behind poten-
tial benefits of MIPD. The analyzed studies may be prone to
selection bias as a difference in the tumor size between groups
has been documented. All these aspects are difficult to avoid
in cohort studies, and therefore well-designed randomized tri-
als are necessary to fully answer the basic question: what are
the potential benefits associated with the introduction of min-
imally invasive surgery to surgical treatment of periampullary
tumors. Although we included only MIPD groups, we did not
analyze the surgical technique (artery first approach vs. tradi-
tional, types of pancreatic and biliary anastomoses, perioper-
ative care used). This obviously may have a significant impact
on final results as previously suggested [45–47].
Conclusions
The findings of this systematic review and subsequent meta-
analysis shows that minimally invasive pancreatic head sur-
gery is not ready for general application and should be per-
formed in specialized high-volume pancreatic centers with
extensive expertise in minimally invasive surgery. Our review
suggests that although MIPD takes longer, it may be associat-
ed with reduced blood loss, shortened LOS, and comparable
rate of perioperative complications. However, it is based on
non-randomized studies only of high-volume specialized cen-
ters. The differences in baseline characteristics of patients may
possibly lead to a high risk of selection bias. In our opinion,
the existing evidence for the use of laparoscopic surgery in
pancreatic head malignancy is very limited and should be
interpreted with caution. This supports the concept that fur-
ther, better quality studies are needed to provide higher level
of evidence on the benefits of minimally invasive approach in
pancreatic head surgery.
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